BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17394936)

  • 1. Animal-derived surfactants versus past and current synthetic surfactants: current status.
    Moya F; Maturana A
    Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous surfactant therapy: new synthetic surfactants].
    Lacaze-Masmonteil T
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myth: all surfactants are alike.
    Moya F; Javier MC
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):269-74. PubMed ID: 21515101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
    Häfner D; Germann PG; Hauschke D
    Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of surfactant replacement trials.
    Suresh GK; Soll RF
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
    Curstedt T; Johansson J
    Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous surfactant therapy: newer developments.
    Lacaze-Masmonteil T
    Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies: synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant.
    Whitelaw A
    J Perinat Med; 1996; 24(5):427-35. PubMed ID: 8950722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL
    J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent clinical trials of surfactant treatment for neonates.
    Halliday HL
    Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New synthetic surfactants: the next generation?
    Pfister RH; Soll RF
    Biol Neonate; 2005; 87(4):338-44. PubMed ID: 15985757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.
    Moya F
    J Perinatol; 2009 May; 29 Suppl 2():S23-8. PubMed ID: 19399006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.